WWTR1 and cancer: Similarly, overexpression of YAP, the TAZ paralogue, has been found to involve in drug response of mammary [18], ovarian [19, 20], colon [21] and hepatocellular [22–25] cancers to multiple chemotherapeutic and targeted therapies.